Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

acer_therapeutics

Acer’s shares drop 80% as FDA rejects drug for vascular Ehlers-Danlos syndrome

June 26, 2019 Research and Development, Sales and Marketing Acer Therapeutics, Edsivo, pharma

Acer Therapeutics has seen its share value plunge by 80% after it emerged that the FDA had turned down its …
News
shutterstock_273326141

AbbVie poised to acquire Allergan for $63 billion

June 26, 2019 Research and Development, Sales and Marketing AbbVie, Allergan, acqusition, pharma

The industry has been rocked with the announcement of another pharmaceutical mega-merger, as it emerged that AbbVie had sealed an …
News

China urges firms to make generic versions of 34 drugs

June 25, 2019 Research and Development China, NHC, generic drugs, generics, patents, pharma

China’s National Health Commission (NHC) has urged generic drugmakers to pick up the production of 34 drugs that are not …
News
w36

FREE WEBINAR: Virtually engaged or engaged virtually?

June 25, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, Within3, pharma

In just over a week, on Wednesday 4 July, Pharmafocus will be collaborating with Healthcare Engagement Solutions firm Within3 to …
News
brexit

The Brexit ‘cliff edge’: How life sciences can survive

June 24, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UK, brexit, pharma

Characterised by a persistent lack of clarity and a political climate that has everyone guessing from week to week, Brexit …
Feature
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 21, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, GSK, MSD, Parkinson's, blockchain, brexit, top ten

It’s Friday, and time for another run-down of the week’s most popular articles.
News
shutterstock_114045100

Sanofi to axe 466 R&D positions in Germany and France

June 21, 2019 Medical Communications, Research and Development, Sales and Marketing Sanofi, pharma

Sanofi has announced that plans to reorganise its research and development operations will result in the losses of 466 jobs …
News
800px-blausen_0704_parkinsonsdisease

Scientists at King’s College London identify early signs of Parkinson’s disease

June 20, 2019 Research and Development King's College London, Kings College London, Parkinson's disease, pharma, serotonin

Scientists at King’s College London say they have identified the earliest signs of Parkinson’s disease in the brain – 15 …
News
gilead-sciences

Gilead signs deal with Nurix Therapeutics worth more than $2.3 billion

June 20, 2019 Business Services, Research and Development Gilead, Nurix Therapeutics, pharma, protiens

Gilead has signed a deal with San Francisco biotech Nurix Therapeutics – a company focused on developing drugs that control …
News
28246711066_52e38bc591_z

No-deal Brexit could cause shortages and higher prices, healthcare distributors warn

June 19, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, UK, brexit, distribution, pharma, supply chain

The Healthcare Distribution Association (HDA) has warned MPs that Britain could face shortages of medicines if it were to leave …
News

NICE recommends Amgen’s Blincyto in rare acute lymphoblastic leukaemia sub-population

June 19, 2019 Research and Development, Sales and Marketing Amgen, Cancer, NICE, acute lymphoblastic leukaemia, blincyto, pharma

Patients on the NHS in England and Wales will now be able to access Amgen’s Blincyto (blinatumomab) after NICE reveals …
News

Contract manufacturing services industry set to grow at CAGR of 10.6% between 2017-2027

June 19, 2019 Research and Development EU, Europe, biopharma, contract manufacturing services, manufacturing, pharma

The biopharmaceutical contract manufacturing market is expected to grow at a compound annual growth rate (CAGR) of 10.6% between 2017 …
News
merck-keytruda

MSD’s Keytruda snatches up first approval in small cell lung cancer

June 19, 2019 Research and Development, Sales and Marketing Cancer, FDA, MSD, US, keytruda, lung cancer, pharma

MSD has revealed that its anti-PD-1 immunotherapy Keytruda (pembrolizumab) has been awarded marketing authorisation from the FDA as a monotherapy …
News
european_commission_web_5

EU pharmaceutical industry lost €16.5 billion in sales as staff shift to patent infringing firms

June 19, 2019 Research and Development EU, counterfeit, generics, pharma, sales

A report from the European Union Intellectual Property Office (EUIPO) has said ‘counterfeit’ drugs cost the EU pharmaceutical industry €16.5 …
News
16792957331_d9572dbdf4_z

FDA expand Paragraph IV Patent Certifications List for generic drugmakers

June 19, 2019 Research and Development FDA, Hatch-Waxman act, generic drugs, generics, pharma

The FDA has said that it is expanding a database used by generic drugmakers to get information on when their …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026